Hospital specialists, not general practices, will decide who is eligible for the country’s first COVID-19 preventive medication, says RNZCGP medical director Bryan Betty
“It is a very small, select, number who will benefit from this medication”
Access to the first preventive medicine for COVID-19 will be limited t, Evusheld tixagevimab cilgavimab, Evusheld is a combination of two monoclonal antibodies [photo: supplied]
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management